Clinical Trial Update: Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO [Phase 4]

View source ↗

Summary

Phase 4 trial comparing intravitreal dexamethasone to bevacizumab in Aboriginal people with diabetic macular edema and diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• Bevacizumab (bevacizumab)
• intravitreal dexamethasone (dexamethasone)

Snippet

Sponsor: Lions Eye Institute, Perth, Western Australia | Conditions: Diabetic Macular Edema, Diabetic Retinopathy | Phase 4 | Status: COMPLETED